Introduction
Arginine vasopressin (AVP) is a nanopeptide synthesized in the hypothalamus and then transported to the posterior pituitary gland where it is released to the systemic circulation. Its release increases with a drop in blood volume or systemic dehydration. AVP performs multiple tasks in blood pressure control, water reabsorption, gluconeogenesis, neurotransmission and platelet aggregation, depending on cell types and receptor species (2, 11) . Three subtypes of AVP receptors have been found: V1a, V2 and V1b. The V1a receptor is mainly expressed in vascular smooth muscle cells, while it is also found in hepatocytes and platelets. In these cells, AVP plays an important role in vasoconstriction, hepatic gluconeogenesis and platelet aggregation through the V1a receptor (11) . The V2 receptor is expressed in the collecting duct principal cells of medullary nephrons, regulating water reabsorption (1) . The V1b receptor is mainly expressed in the pituitary gland (8) . Acting on the V1a receptor, AVP is a potent vasoconstrictor and has been widely used for therapeutical purposes (12) . Under certain conditions such as septic shock when G-adrenergic stimulants lose vasoconstriction capability, AVP remains, to a large degree, to be an effective vasoconstrictor (31) .
Several Ca

2+
-permeable channels are activated by AVP including the T-type Ca 2+ channels, L-type Ca 2+ channels and the voltage-dependent receptor-operated cation channels (4, 18, 22) . The opening of these channels contributes to the rise in cytosolic Ca As the major vascular isoform, the Kir6.1/SUR2B channel plays an important role in vascular tone regulation. Kir6.1 knockout mice exhibited a high rate of sudden death associated with spontaneous electrocardiographic ST elevation followed by atrioventricular block, which resembles Prinzmetal angina in humans (23) . Genetic disruption of the abcc9 (SUR2) gene leads to coronary artery vasospasm and raises resting blood pressures (5) . The spontaneous coronary vasospasm persists in the abcc9-knockout mice with restored expression of K ATP channels in vascular smooth muscles, suggesting that a process extrinsic to the coronary arterial smooth muscle may be involved (17) . Vascular K ATP channels are targeted by several vasoactive hormones and neurotransmitters (3) . However, the modulation of the vascular K ATP channels by AVP is still controversial (6, 38) . There is evidence that K ATP channels in cardiac myocytes and the insulinoma cell line are also inhibited by AVP suggesting that Kir6.2/SUR1 and Kir6.2/SUR2A channels are targeted (21, 36) . Since functional vascular K ATP channels are mainly made of Kir6.1 with SUR2B subunits, the understanding of K ATP channel contribution to vascular tones relies on the demonstration of the precise signal network between neurotransmitters/hormones and K ATP channels. To test the hypothesis that Kir6.1/SUR2B channel is one of the effectors of AVP, we performed these studies. Our results indicated that the Kir6.1/SUR2B channel was inhibited by AVP through V1a receptor, and the channel inhibition relied on intracellular signal systems involving PKC.
Materials and Methods
Cell culture
Rat Kir6.1 (GenBank #D42145) and mouse SUR2B (GenBank #D86038) were cloned in a eukaryotic expression vector pcNDA3.1 and used for mammalian cell expression. Human AVP receptor 1A with N-terminal 3XHA tag (AVPR1A, GenBank ACC# AY322550) in pcNDA3.1 was purchased from www.cDNA.org (Rolla, MO). Wild type V1a receptor was prepared by removing 3XHA-tag with PCR and cloned into pcNDA3.1.
Human embryonic kidney cells (HEK293, CRL-1573, Batch #2187595, ATCC, Rockville, MD) were chosen to express the K ATP channels. The HEK293 Cells were cultured as monolayer in the DMEM-F12 medium with 10% fetal bovine serum and penicillin/streptomycin.
Maintained at 37 °C with 5% CO 2 in atmospheric air, the cells were routinely split twice a week.
The HEK293 cells were transfected using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) in which 0.7Mg Kir6.1, 2.1Mg SUR2B and 1.8Mg V1a receptor were added to a 35mm petri dish.
To facilitate the identification of positively transfected cells, 0.5Mg green fluorescent protein (GFP) cDNA (pEGFP-N2, Clontech, Palo Alto, CA) was added to the cDNA mixture. Cells were dissociated from the monolayer using 0.25% trypsin ~24 hrs post-transfection. A few drops of the cell suspension were added on to 5×5 mm cover slips in a 35mm petri dish. The cells were then incubated at 37 °C for 24-48h before experiments.
Acute dissociation of vascular smooth myocytes
The surgical procedure for dissection of mesenteric arteries has been described previously (39). All animal experiments complied with the IACUC approval of the Georgia State University. Sprague-Dawley rats (250-350g) were anesthetized by inhaling saturated halothane vapor followed by cervical dislocation. Mesenteric arteries were dissected free, cut into small segments (1-2 mm), and placed in 5ml solution containing (in mM): 140 NaCl, 5. . In this study, we used NP o instead of P o to express overall channel activity, in which the number of openings was not counted.
Isolated mesenteric arterial ring
Mesenteric arteries were obtained as mentioned above, and 2-4 animals were used in the study in each group. The endothelium of the rat mesenteric arteries was kept intact, because the contractile responses to AVP in the rat mesenteric artery are not critically dependent on the endothelium (32) . The endothelium-free rings were prepared by gently rubbing with a sanded polyethylene tube, and confirmed with vasodilation response to acetylcholine. The isolated mesenteric arteries were transferred to ice-cold Krebs solution containing NaCl 118.0, NaHCO 3 25.0, KCl 3.6, MgSO 4 1.2, KH 2 PO 4 1.2, glucose 11.0, CaCl 2 2.5 in mM (42). A ring segment 2mm in length was mounted on a force-electricity transducer (Model FT-302, iWorx/CBSciences, Inc. Dover, NH) in a tissue bath with 5 ml Krebs solution. With a 0.8 g preload added added, the rings were allowed to equilibrate in the tissue bath for 30 min, and then the tension was reduced to ~0.6g. The tissue bath was filled with Krebs solution and perfused with 5% CO 2 at 36°C. Arterial tone was measured as changes in isometric force. The rings that showed vasoconstriction response induced by 10 MM phenylephrine (PE) were used to study. PE was then washed out and the tension was returned to the baseline levels before the administration of the following drugs.
Chemicals and drugs
PKC inhibitor peptide 19-31 (PKCi) was purchased from Calbiochem, La Jolla, CA. AVP, glibenclamide, pinacidil and PMA were applied to cells using a perfusion system. AVP was administrated after the maximum current activation by pinacidil was reached. PKCi was included in the pipette solution (10 µM). To avoid ATP degradation, all ATP-containing solutions were made immediately before experiments and used for no longer than 4 hrs. Since the variation of Cl V concentrations in solutions was rather small, the resulted liquid junction potential was less than 1mV according to the Henderson equation, and was thereby not corrected.
Data analysis
The concentration-response relationship was fitted with the regular Hill equation: 
Results
Expression of Kir6.1/SUR2B channels in HEK293 cells
Expression of AVP receptors in HEK293 cells has been successfully used to identify signal pathways of AVP (15, currents reported previously (33, 39, 43).
Inhibition of Kir6.1/SUR2B channels by AVP
When V1a receptor was co-transfected with Kir6.1/SUR2B in HEK293 cells, the currents activated by 10 MM pinacidil were strongly inhibited with an exposure to 100 nM AVP plus 10
MM pinacidil (Fig. 1A) . For quantitative analysis, we normalized the affected currents between maximum channel inhibition by 10MM glibenclamide and maximum activation by 10MM
pinacidil. Evident channel inhibition was seen with 300 pM AVP (16.6±8.1%, n=8), and stronger inhibition occurred with higher concentrations, with 1 nM (26.4±10.9%, n=6), 3 nM (52.2±10.6%, n=8). The concentration-response relationship can be described using the Hill equation with IC 50 2.0 nM, and the Hill coefficient (h) 1.0 (Fig. 2B ). The maximal inhibition was reached with 10 nM AVP (62.9±10.7%, n=5). Higher concentration showed slightly further inhibitory effect, with 30 nM AVP (64.0±9.6%, n=11), 100 nM AVP (66.0±5.4%, n=8), and 300 nM AVP (66.8±8.6%, n=6). The Kir6.1/SUR2B currents were also studied in cells transfected without V1a receptor, in which no evident inhibition of the Kir6.1/SUR2B currents was seen with 100 nM AVP (Fig. 1B) .
Biophysical mechanisms
In whole-cell recordings, the currents activated by pinacidil showed almost a linear conductance with no obvious rectification, which was consistent with previous reports (43). The currents inhibited by AVP were isolated by subtracting the remaining currents from the maximum currents activated by pinacidil. When the I-V relationship of the currents was plotted with the pinacidil-activated currents, they superimposed almost completely (Fig. 3G ), indicating that effect of AVP is not voltage-dependent.
In cell-attached patches, currents with single-channel conductance of 39.1 ± 3.3 pS (n = 8)
were observed. Exposure of the cells to 10 MM pinacidil increased NP o from 0.021±0.030
to 0.140±0.072 (Fig. 4) . AVP subsequently reduced NP o to 0.037±0.026 (P<0.01, n=5). In contrast to NP o , single-channel conductance did not show any significant change in the presence of AVP (38.0 ± 4.7 pS, n = 8) (Fig. 4) . Therefore, these results suggest that the inhibition of whole-cell Kir6.1/SUR2B currents by AVP is produced by the suppression of the NP o without affecting the single-channel conductance.
PKC dependence
Previous studies have shown that Kir6.1/SUR2B channel activity is affected by both protein kinase A (PKA) and PKC (29, 35) . The V1a receptor is known to be coupled to Gprotein GG q , activation of which leads to activation of phospholipase C and PKC (13) . Therefore, it is possible that the Kir6.1/SUR2B channel inhibition by AVP is mediated by activation of the PKC pathway. To test the hypothesis, we studied the Kir6.1/SUR2B channel by interference with the PKC signaling system. Phorbol 12-myristate 13-acetate (PMA) is a potent PKC agonist that anchors PKC to cellular membrane and persistently exposes its catalytic site (26) . Administration of 100 nM PMA reduced the pinacidil-activated currents by 84.5±5.9% (n=6) (Fig. 5A ). In the presence of PMA, 100 nM AVP had no significant inhibitory effect on the currents (8.4±5.1%, n=6). In contrast, inactive phorbol ester, 4G-Phorbol 12, 13-didecanoate (4G PDD) had little inhibitory effect (13.3±8.5%, n=4), and the whole currents were further inhibited by 100 nM AVP (63.9±9.9%, n=4) after the cells were pretreated with 4G PDD (Fig. 5 D,E) . With a pretreatment with 100 nM calphostin-C a selective PKC blocker for 20 min, the inhibitory effect of AVP was significantly diminished (15.4±1.7%, n=5, P<0.01). When the pipette solution contained PKCi (10 µM) (Fig. 5B,E) , which acted as a pseudo substrate by binding to the catalytic site of PKC, 100 nM AVP did not produce any significant channel inhibition (3.2±5.1%, n=5, P>0.05) (Fig. 5C,E) . Taken together, all these results suggest that the Kir6.1/SUR2B channel inhibition by AVP is very likely to be mediated through the PKC system.
Effects of AVP on endogenous currents of vascular smooth myocytes.
Vascular smooth myocytes (VSMs) were freshly dissociated from the mesenteric arteries (Fig. 6A ). Whole-cell currents were recorded from these cells under the same condition as for the HEK293 cells. The VSMs showed small baseline currents, and the current amplitude increased markedly with an exposure to 10µM pinacidil. The pinacidil-activated currents were strongly inhibited by 100nM AVP in the presence of pinacidil (by 63.1±5.3%, n=6) (Fig. 6B,E) .
In cell-attached patches, a K + current with single-channel conductance of ~35pS was observed in the acutely dissociated VSMs (Fig. 6C) . The current had rather low baseline activity with NP o 0.004±0.002 (n=4), consistent with a previous report (25) . The channel activity increased with an exposure to 10µM pinacidil, and was inhibited with 100nM AVP in the extracellular solution (Fig. 6D,E) . The pinacidil-activated current had single-channel conductance of 34.8±1.1pS (n=4), which did not change significantly with AVP (35.3±0.8pS, n=4, P>0.05). Application of glibenclamide led to a further inhibition of this current. Therefore, these pharmacological properties of this 35pS current were consistent with our observations in the whole-cell recordings from the VSMs, suggesting that the VSM-endogenous K ATP channel is inhibited by AVP.
Constriction of mesenteric artery by activation of V1a receptors
AVP produced concentration-dependent constrictions of the isolated mesenteric artery rings with EC 50 6.5 nM (Fig. 7A,B) . At the maximum effect, pinacidil relaxed the vasoconstriction almost completely in the continuing presence of AVP, strongly suggesting K ATP channel is involved (Fig. 6A) . A repetitive exposure of AVP in 45 min after the first treatment did not significantly change the reactivity of vascular ring (0.40±0.05 g and 0.37±0.05 g, respectively, n=5 rings from 2 animals, P>0.05, Fig. 7C ). This effect did not seem to be mediated through endothelium, as AVP remained producing contractions in endothelium-free rings (0.52±0.09g, n=3, Online Fig. 1 ). The effect of AVP was blocked by 30 nM YM-AVP, a selective V1a receptor blocker (Fig. 7D,F) (0.260±0.002 g and 0.028±0.000 g, respectively, n=4, P<0.05). The AVP-induced vasoconstriction was attenuated by a pre-exposure to 1 MM calphostin-C (P<0.05, n=4; Fig. 7E,F) . Similar to the effect of AVP, application of PMA (1MM) produced vasoconstriction (0.41±0.16g, n=5) that was relaxed by 10MM pinacidil (0.05±0.03g, n=5 rings from 4 animals).
Discussion
Our results from the present study indicate that the VSM isofom of K ATP channels is one of the major targets of AVP. We have found that AVP strongly inhibits Kir6. showing that PKC regulates K ATP channels through gating mechanism although the PKC phosphorylation sites were still unidentified (28, 35) . Therefore, it is possible that the channel gating mechanisms are targeted by PKC phosphorylation. In addition to direct phosphorylation of the channel protein, the internalization or endocytosis of V1a receptor and/or Kir6.1/SUR2B channel may be another mechanism for the decrease in functional channel activity, as shown previously for the Kir6.2 channel (14) . In our in-vitro experimental condition, the low baseline activity of VSM-endogenous K ATP channel is consistent with a previous report (25) . Since the K ATP channels strongly activated by several vasodilating hormones through the PKA system (41), it is possible the channel may maintain fair basal activity in-vivo as suggested previously (27) . Since how the Kir6.1/SUR2B channel is inhibited by the PKC pathway is still unclear, the demonstration of the target molecule of AVP and the involvement of PKC should be helpful for further investigations.
AVP is a potent vasoconstrictor that has been known to be useful when systemic circulation loses its reactivity to traditional anti-shock drugs, such as epinephrine and dopamine during septic shock, a severe infection disease with the overall mortality rate 49.7% (9) . The rationale for the application of AVP is its relative lower plasma concentration (1 pg/ml, 10 -12
M)
and hypersensitivity to its vasoconstrictor effects during such a pathological condition (24) .
Therapeutical application of AVP can be even more effective if its target molecules and critical intracellular signal pathways are known. In this regard, our current studies appear to constitute a significant step toward the understanding of vascular regulation by AVP and K ATP channels. The currents did not respond to 100 nM AVP, while they were still inhibited by glibenclamide (10µM). 
